# Lek Pharmaceuticals – FDA Inspection, Apr 6, 2012

Source: https://www.keypedia.com/records/fda_inspections/lek-pharmaceuticals/722555c1-703e-47b6-be9e-48df47a35d48
Source feed: FDA_Inspections

> FDA inspection 779021 of Lek Pharmaceuticals, April 06, 2012. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 779021
- Company Name: Lek Pharmaceuticals
- Inspection Date: 2012-04-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1246916 - 2024-07-26
- FDA Inspection 1254088 - 2023-12-11
- [FDA Inspection 1178973 - 2022-03-18](https://www.keypedia.com/records/fda_inspections/lek-pharmaceuticals/45b6f40d-76b3-4a3a-ba54-df7addeaffc4)
- [FDA Inspection 1045912 - 2018-02-20](https://www.keypedia.com/records/fda_inspections/lek-pharmaceuticals/1c205713-c9e8-42a5-aac4-7e8e5a858fac)
- [FDA Inspection 1005712 - 2017-02-24](https://www.keypedia.com/records/fda_inspections/lek-pharmaceuticals/86ecc7de-f878-448b-910f-cb7f2cb553f8)

Company: https://www.keypedia.com/companies/lek-pharmaceuticals/6b651b9c-9e4f-46ac-a02a-ddc22f9bc3a6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c